- Home
- SAGE vs OBE Comparison
SAGE vs OBE Comparison
Compare SAGE & OBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- OBE
- Stock Information
- Founded
- SAGE 2010
- OBE 1979
- Country
- SAGE United States
- OBE Canada
- Employees
- SAGE N/A
- OBE N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- OBE Oil & Gas Production
- Sector
- SAGE Health Care
- OBE Energy
- Exchange
- SAGE Nasdaq
- OBE Nasdaq
- Market Cap
- SAGE 462.2M
- OBE 432.5M
- IPO Year
- SAGE 2014
- OBE N/A
- Fundamental
- Price
- SAGE $5.01
- OBE $5.94
- Analyst Decision
- SAGE Hold
- OBE Strong Buy
- Analyst Count
- SAGE 20
- OBE 1
- Target Price
- SAGE $12.89
- OBE $14.00
- AVG Volume (30 Days)
- SAGE 854.9K
- OBE 389.9K
- Earning Date
- SAGE 10-29-2024
- OBE 10-31-2024
- Dividend Yield
- SAGE N/A
- OBE N/A
- EPS Growth
- SAGE N/A
- OBE N/A
- EPS
- SAGE N/A
- OBE 1.05
- Revenue
- SAGE $106,399,000.00
- OBE $516,155,298.00
- Revenue This Year
- SAGE N/A
- OBE $28.71
- Revenue Next Year
- SAGE $118.26
- OBE $12.85
- P/E Ratio
- SAGE N/A
- OBE $4.86
- Revenue Growth
- SAGE 837.60
- OBE 3.06
- 52 Week Low
- SAGE $4.62
- OBE $5.24
- 52 Week High
- SAGE $28.26
- OBE $9.07
- Technical
- Relative Strength Index (RSI)
- SAGE 32.20
- OBE 54.10
- Support Level
- SAGE $4.62
- OBE $5.46
- Resistance Level
- SAGE $5.87
- OBE $5.73
- Average True Range (ATR)
- SAGE 0.39
- OBE 0.22
- MACD
- SAGE -0.10
- OBE 0.02
- Stochastic Oscillator
- SAGE 21.18
- OBE 65.00
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Crude oil sale.